Display options
Cite
Ai J, Zhang H, Zhang Y, et al. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect. 2021;1-24doi: 10.1080/22221751.2021.2022440.
Ai, J., Zhang, H., Zhang, Y., Lin, K., Zhang, Y., Wu, J., Wan, Y., Huang, Y., Song, J., Fu, Z., Wang, H., Guo, J., Jiang, N., Fan, M., Zhou, Y., Zhao, Y., Zhang, Q., Liu, Q., Lv, J., Li, P., Qiu, C., & Zhang, W. (2021). Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerging microbes & infections, 1-24. https://doi.org/10.1080/22221751.2021.2022440
Ai, Jingwen, et al. "Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost." Emerging microbes & infections vol. (2021): 1-24. doi: https://doi.org/10.1080/22221751.2021.2022440
Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, Wang H, Guo J, Jiang N, Fan M, Zhou Y, Zhao Y, Zhang Q, Liu Q, Lv J, Li P, Qiu C, Zhang W. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect. 2021 Dec 22;1-24. doi: 10.1080/22221751.2021.2022440. Epub 2021 Dec 22. PMID: 34935594.
Copy Download .nbib Format: NLM
Share it on

Emerg Microbes Infect. 2021 Dec 22;1-24. doi: 10.1080/22221751.2021.2022440. Epub 2021 Dec 22.

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.

Emerging microbes & infections

Jingwen Ai, Haocheng Zhang, Yi Zhang, Ke Lin, Yanliang Zhang, Jing Wu, Yanming Wan, Yanfang Huang, Jieyu Song, Zhangfan Fu, Hongyu Wang, Jingxin Guo, Ning Jiang, Mingxiang Fan, Yang Zhou, Yuanhan Zhao, Qiran Zhang, Qiang Liu, Jing Lv, Peiyao Li, Chao Qiu, Wenhong Zhang

Affiliations

  1. Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai 200040, China.
  2. Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Jiangsu, 210001, China.
  3. Gobond Testing Technology (Beijing) Co., Ltd, No. 38 Yongda Road, Beijing, 102629, China.
  4. Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  5. State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai 200438, China.
  6. National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.

PMID: 34935594 DOI: 10.1080/22221751.2021.2022440

[No abstract available.]

Publication Types